Plasma Definition & Meaning | Health Care Term | CSIMarket
CSI Market
Sign In | Register

Glossary

Plasma

Health Care Term

Plasma is a yellow fluid that makes up about 55% of the blood in the human body. It is a complex mixture of proteins, electrolytes, hormones, and other nutrients required for proper cellular function. Plasma plays an important role in maintaining the proper balance of fluids and electrolytes in the body, as well as transporting nutrients and waste products between cells and tissues.

In the health care industry, plasma is used in a number of ways. One common use is in the treatment of patients with severe or life-threatening illnesses, such as burns, shock, and bleeding disorders. Medical professionals can use plasma transfusions to replace lost fluids and restore critical nutrients to these patients. In particular, plasma contains a range of clotting factors that are essential for blood to properly clot, and it is often used to treat patients with clotting disorders.

Plasma is also used in the production of a wide range of diagnostic and therapeutic products. For example, it can be used to manufacture clotting factors, immune globulins, and albumin, which are used to treat a range of medical conditions, including hepatitis, autoimmune disorders, and viral infections.

Overall, plasma plays a vital role in maintaining human health, and its use in the health care industry has contributed significantly to improving patient outcomes and quality of life.




More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P